Stratview Research has published a new report titled “Specialty Enzymes Market” which is segmented by Type (Carbohydrases [Amylases, Cellulases, and Other Carbohydrases], Proteases, Lipases, Polymerases & Nucleases, and Others), by Application Type (Pharmaceuticals, Research & Biotechnology, Diagnostics, and Biocatalysts), by Source Type (Microorganisms, Plants, and Animals), by Form Type (Liquid and Dry), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).

As per the study, the specialty enzymes market size was valued at USD 4.82 billion in 2021 and is likely to grow at a CAGR of 7.06% during 2022-2028 to reach USD 7.8 billion in 2028.

What are specialty enzymes?

Specialty Enzymes are proteins that serve as biocatalysts to augment the rate of reactions and produce the desired results in pharmaceuticals and diagnostics reactions.

Specialty Enzymes are of different types, such as carbohydrases, proteases, lipases, polymerases & nucleases, and others, that are used in various applications such as pharmaceuticals, research & biotechnology, diagnostics, and biocatalysts.

COVID-19 IMPACT

The covid-19 pandemic shook the whole world, and the impact was felt across almost every industry. The pandemic had a negative impact on the growth of the Specialty Enzymes Market due to lockdowns and restrictions implied in various countries.

Market Dynamics

The major factors driving the growth of the specialty enzymes market are-

• The present surge in the non-hazardous biological catalysts in pharmaceuticals and diagnostics.
• The advanced development in tools to maximize pharmaceutical production & quality.
• Multi-functional advantages of specialty enzymes.

Report Highlights

This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the market dynamics of the industry. It provides a thorough analysis of the market segments which include products, applications, and competitor analysis.

The market is bifurcated into various segments. Below given is the segment-wise analysis –

Based on the type, the market is segmented as carbohydrases, proteases, lipases, polymerases & nucleases, and others. The polymerases & nucleases segment is expected to dominate the market during the forecast period, owing to their usage in special applications such as pharmaceuticals, research & biotechnology, diagnostics, and biocatalysts.

Also, being the essential parts for all nucleic acid processing including replication, repair, recombination & transcription, makes they support the catalysis of the synthesis of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) polymers, ushering the segment towards unprecedented growth.

Based on the application type, the specialty enzymes market is segmented as pharmaceuticals, research & biotechnology, diagnostics, and biocatalysts. The pharmaceuticals segment dominates the market, owing to the increase in its application in the pharmaceutical industry, mainly for drug manufacture, disease diagnostics, or as therapy. There has been an increase in the usage of specialty enzymes for therapies such as cancer, cardiovascular diseases, lysosomal storage disorders, and pain and inflammation management, which also acts as a driving factor for the growth of the segment.

Based on the source type, the market is segmented into microorganisms, plants, and animals. The microorganisms segment is expected to grow at the highest growth rate, as enzymes extracted from microbial sources lead to low production costs, can be cultured in large quantities in a short period of time, and contain more predictable and controllable enzyme content.

In terms of regions, North America is estimated to be the largest-growing market for specialty enzymes during the forecast period. Technological advancements, the availability of enzymes for a wide range of applications, the development of novel & superior-performing products, and global industrialization are driving the region’s market, along with an increase in the usage of enzymes in the region’s pharmaceutical industry. Further, the US is estimated to be the dominant market in the North American region and is at the stage to reach maturity very sooner.

About Us

Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.